- Healthcare Huddle
- Posts
- A Comprehensive Analysis of Mark Cuban's Cost Plus Drugs Company
A Comprehensive Analysis of Mark Cuban's Cost Plus Drugs Company
Huddle+ | Huddle #Trends
Jared Dashevsky, MD
February 04, 2024 • Estimated Reading Time: 2 minutes
Huddle #Trends are monthly reports dissecting key healthcare trends that impact patients, physicians, and the system. Exclusive to Huddle+ members.
Mark Cuban launched online pharmacy Cost Plus Drugs in January 2022, promising to offer common, life-saving generic medications that are half the price elsewhere.
The company has certainly upheld its promise.
Since they launched, Cost Plus Drugs has gained 2 million customers, added thousands of low-cost generic drugs to its platform, and formed hundreds of strategic partnerships. As the company enters its third year of operations, it’s only fitting to dive into the company to highlight its growth and impact on the market.
Subscribe to Huddle+ to read the rest.
Become a paying subscriber of Huddle+ to get access to this post and other subscriber-only content.
Already a paying subscriber? Sign In.
A subscription gets you:
- • Traditional Sunday Healthcare Huddle newsletter and...
- • Exclusive Content: Weekly Inefficiency Insights and Monthly Huddle #Trends newsletters
- • Huddle University: Courses on essential healthcare topics
- • The Huddle Community: Connect with a network of healthcare professionals, share insights, and stay ahead in the industry
- • Discount for physicians, trainees, providers, students, employers. Email [email protected]
Reply